The assessment of the mechanism of action of bergenin revealed that its treatment to CRC cells reduced Akt/GSK3β signaling activity, suggesting that it could promote FBW7-mediated Mcl-1 degradation and ultimately apoptosis in CRC cells. The gene discussed is GSK3B; the disease is colorectal carcinoma.